Stephen V Liu posted on X:
“Opening session of the 2024 Thomas Shea Clinical Cancer Symposium UNC Lineberger chaired by Jared Weiss included great insights into molecular testing (role of AI, LDT) from Drs. Jason Mercer, Norman Sharpless and advances in targeted therapy from Drs. Shetal Patel and Mark Socinski.”
Source: Stephen V Liu/X
Stephen V Liu is an Associate Professor of Medicine at Georgetown University, where he holds the positions of Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center. As a board-certified medical oncologist specializing in lung cancer and drug development, Dr. Liu is known for his expertise in advanced thoracic malignancies.
His research focuses on novel therapeutic agents and innovative combinations to improve treatment outcomes for patients with lung cancer. Dr. Liu has received multiple teaching awards and actively engages in post-graduate education initiatives. Furthermore, he co-hosts the official podcast of the International Association for the Study of Lung Cancer (IASLC), “Lung Cancer Considered”.
